Veeva Systems (VEEV)

• Market cap: $34.1B
• 1 day: 0.35%
• 5 days: -9.68%
• 1 month: -5.08%
• 3 months: 8.76%
• 6 months: 0.32%
• Year to date: 11.34%
• 1 year: 17.86%
• 5 years: 36.48%
• 10 years: 656.85%
• Sector: Information Technology
• Industry: Prepackaged Software

About: Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Employees: 7,172

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

33% more funds holding in top 10

Funds holding in top 10: 12 [Q2] → 16 (+4) [Q3]

30% more first-time investments, than exits

New positions opened: 125 | Existing positions closed: 96

12% more capital invested

Capital invested by funds: $23.5B [Q2] → $26.4B (+$2.87B) [Q3]

3% more funds holding

Funds holding: 898 [Q2] → 927 (+29) [Q3]

9% more repeat investments, than reductions

Existing positions increased: 349 | Existing positions reduced: 319

9% less call options, than puts

Call options by funds: $248M | Put options by funds: $272M

1.82% less ownership

Funds ownership: 79.41% [Q2] → 77.58% (-1.82%) [Q3]

Research analyst outlook

20 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $192 9% downside
• Avg. target: $245 16% upside
• High target: $286 36% upside

20 analyst ratings

• positive: 14 70%
• neutral: 6 30%
• negative: 0 0%

Scotiabank Allan Verkhovski 80% 1-year accuracy 4 / 5 met price target	12% upside $235	Sector Perform Initiated	18 Nov 2024
Barclays Saket Kalia 61% 1-year accuracy 25 / 41 met price target	23% upside $260	Overweight Maintained	8 Nov 2024
RBC Capital Rishi Jaluria 49% 1-year accuracy 28 / 57 met price target	31% upside $275	Outperform Maintained	8 Nov 2024
Needham Ryan MacDonald 54% 1-year accuracy 20 / 37 met price target	23% upside $260	Buy Reiterated	8 Nov 2024
Piper Sandler Brent Bracelin 62% 1-year accuracy 56 / 90 met price target	33% upside $280	Overweight Maintained	8 Nov 2024